Literature DB >> 22930111

[Systematic literature research for S1 guidelines on sequential medical treatment of rheumatoid arthritis].

K Albrecht1, K Krüger, U Müller-Ladner, J Wollenhaupt.   

Abstract

BACKGROUND: On behalf of the German association of Rheumatology national experts developed guidelines for the medical treatment of rheumatoid arthritis (RA) based on the EULAR recommendations for the management of RA published in 2010. Current evidence was provided with an update of the systematic literature review (SLR). The methods and results of the SLR are presented in this article.
MATERIALS AND METHODS: An update of the EULAR SLR for the medical treatment of RA was performed from January 2009 to August 2011. The SLR assessed all controlled studies dealing with the outcome in clinical aspects, function and structure of disease modifying treatment of RA.
RESULTS: Out of 6,869 screened publications, 138 articles and 56 abstracts were considered in the development of the German guidelines on the treatment of RA. A modified set of recommendations was approved in a consensus of national experts.
CONCLUSION: A systematic literature research provided current evidence for the German recommendations on the sequential medical treatment of RA.

Entities:  

Mesh:

Year:  2012        PMID: 22930111     DOI: 10.1007/s00393-012-1048-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  63 in total

1.  Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis.

Authors:  Monica Todoerti; Carlo Alberto Scirè; Nicola Boffini; Serena Bugatti; Carlomaurizio Montecucco; Roberto Caporali
Journal:  Ann N Y Acad Sci       Date:  2010-04       Impact factor: 5.691

2.  Unifying abbreviations for biologics in rheumatology--does the idea hold promise?

Authors:  Ulf Müller-Ladner
Journal:  Rheumatology (Oxford)       Date:  2009-03-20       Impact factor: 7.580

3.  Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.

Authors:  R F van Vollenhoven; S Ernestam; P Geborek; I F Petersson; L Cöster; E Waltbrand; A Zickert; J Theander; A Thörner; H Hellström; A Teleman; C Dackhammar; F Akre; K Forslind; L Ljung; R Oding; A Chatzidionysiou; M Wörnert; J Bratt
Journal:  Lancet       Date:  2009-08-08       Impact factor: 79.321

4.  Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.

Authors:  Niels Graudal; Gesche Jürgens
Journal:  Arthritis Rheum       Date:  2010-10

5.  Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

Authors:  Jeffrey D Greenberg; Joel M Kremer; Jeffrey R Curtis; Marc C Hochberg; George Reed; Peter Tsao; Michael E Farkouh; Adeel Nasir; Soko Setoguchi; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

6.  The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.

Authors:  Vappu Rantalaiho; Markku Korpela; Pekka Hannonen; Hannu Kautiainen; Salme Järvenpää; Marjatta Leirisalo-Repo; Markku Hakala; Kari Puolakka; Heikki Julkunen; Riitta Luosujärvi; Timo Möttönen
Journal:  Arthritis Rheum       Date:  2009-05

Review 7.  Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis.

Authors:  Wanruchada Katchamart; Judith Trudeau; Veerapong Phumethum; Claire Bombardier
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

8.  Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort.

Authors:  M Soubrier; C Lukas; J Sibilia; B Fautrel; F Roux; L Gossec; S Patternotte; M Dougados
Journal:  Ann Rheum Dis       Date:  2011-01-17       Impact factor: 19.103

9.  Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis Register.

Authors:  E M Camacho; M Harrison; T M Farragher; M Lunt; D K Bunn; S M M Verstappen; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2011-04       Impact factor: 19.103

10.  Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.

Authors:  Norihiro Nishimoto; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutomu Takeuchi; Junichi Azuma; Tadamitsu Kishimoto
Journal:  Mod Rheumatol       Date:  2008-11-01       Impact factor: 3.023

View more
  5 in total

1.  [Pharmacotherapy of psoriatic arthritis. Treatment recommendations against the background of limited evidence].

Authors:  M Köhm; F Behrens
Journal:  Z Rheumatol       Date:  2015-06       Impact factor: 1.372

2.  [German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm].

Authors:  K Krüger; J Wollenhaupt; K Albrecht; R Alten; M Backhaus; C Baerwald; W Bolten; J Braun; H Burkhardt; G Burmester; M Gaubitz; A Gause; E Gromnica-Ihle; H Kellner; J Kuipers; A Krause; H-M Lorenz; B Manger; H Nüßlein; H-G Pott; A Rubbert-Roth; M Schneider; C Specker; H Schulze-Koops; H-P Tony; S Wassenberg; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

Review 3.  Rheumatoid arthritis--early diagnosis and disease management.

Authors:  Matthias Schneider; Klaus Krüger
Journal:  Dtsch Arztebl Int       Date:  2013-07-08       Impact factor: 5.594

Review 4.  German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Authors:  Katinka Albrecht; Klaus Krüger; Jürgen Wollenhaupt; Rieke Alten; Marina Backhaus; Christoph Baerwald; Wolfgang Bolten; Jürgen Braun; Harald Burkhardt; Gerd R Burmester; Markus Gaubitz; Angela Gause; Erika Gromnica-Ihle; Herbert Kellner; Jens Kuipers; Andreas Krause; Hans-Martin Lorenz; Bernhard Manger; Hubert Nüßlein; Hans-Georg Pott; Andrea Rubbert-Roth; Matthias Schneider; Christof Specker; Hendrik Schulze-Koops; Hans-Peter Tony; Siegfried Wassenberg; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2013-08-14       Impact factor: 2.631

5.  The new 2012 German recommendations for treating rheumatoid arthritis : differences compared to the European standpoint.

Authors:  J Wollenhaupt; K Albrecht; K Krüger; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2013-02       Impact factor: 1.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.